UNSPSC 51472602: Nitromersol

This classification denotes a topical anti-infective agent with the molecular formula C7H5HgNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RU6242GP15, chemically known as 7-oxa-8-mercurabicyclo(4.2.0)octa-1,3,5-triene, 5-methyl-2-nitro- but generally known as nitromersol, which bears US NIH Compound Identifier 16682935. European Medicines Agency schedules Nitromersol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14659MIG.

As of Q4 2014, NITROMERSOL remains the US FDA Preferred Term for this commodity. Nitromersol bears US NLM identifiers UMLS ID C0301303 and NCI Concept Code C84020. SMILES: [HG]1OC2C1C([N](=O)O)CCC2C..

UNSPSC 51472602 Nitromersol, a Commodity code, identifies antimicrobial chemical products that state and local governments procure as components of janitorial supplies, operational chemicals, and pharmaceutical inventories distributed across public facilities. The code sees activity from county procurement offices and state multistate cooperative purchasing alliances sourcing consumable chemicals for fire rescue operations, public health systems, and institutional facilities on an as-needed basis.

Hillsborough County Board of County Commissioners issued ITB 2600319 on July 7, 2026, seeking janitorial and operational supplies for the Hillsborough County Fire Rescue Department, with bids due July 24, 2026 and an estimated contract value of $765,679.84 for one year; nitromersol and related antimicrobial agents would fall within the consumable chemical supplies this solicitation covers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon, with awarded contracts effective July 1, 2026; this RFP encompasses chemical-based pharmaceutical and OTC products including antimicrobials supplied through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Recent activity concentrates in the Southeast and Upper Midwest, with county-level and state cooperative purchasing bodies as primary issuing parties.